What The White House Is NOT Telling You About The "Green Revolution."

Governments across the globe want to go "All Electric" by 2035. There's one rare metal that could cripple these plans. Without it, going green is impossible. And that's why there's a modern-day gold-rush for this rare metal.

BHVN Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.40%

Insider Buying (Last 12 Months): $6,239,870.00

Insider Selling (Last 12 Months): $16,498,698.66

Biohaven Pharmaceutical Insider Trading History Chart

Biohaven Pharmaceutical Share Price & Price History

^$152.40

▲ +0.2 (0.13%)

As of 09/28/2022 12:51 PM ET

Days: 30 | 90 | 365

Nevada Desert more Valuable than Wall Street or Silicon Valley?

From Investing Trends | Ad

It could be true, according to Nevada Governor Steve Sisolak. The state's desert flats contain more lithium than any other geography in the world. And with electric vehicles driving a global boom in demand for lithium-ion batteries, Nevada should be on every investor's radar.

Find Out How to Take Advantage of Nevada's Lithium

Biohaven Pharmaceutical Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/19/2022	Gregory H. Bailey	Director	Buy	38,000	$148.04	$5,625,520.00	2,583,658
5/10/2022	George C. Clark	CAO	Sell	4,200	$141.50	$594,300.00	4,065
1/19/2022	George C. Clark	CAO	Sell	9,375	$117.01	$1,096,968.75
12/20/2021	George C. Clark	CAO	Sell	1,915	$123.84	$237,153.60
12/20/2021	Julia P. Gregory	Director	Sell	12,000	$125.00	$1,500,000.00
12/15/2021	Elyse Stock	Insider	Sell	21,919	$105.49	$2,312,235.31
12/10/2021	James Engelhart	CFO	Sell	35,000	$102.55	$3,589,250.00
11/29/2021	Declan Doogan	Director	Sell	24,525	$112.80	$2,766,420.00
11/16/2021	Declan Doogan	Director	Sell	37,740	$116.65	$4,402,371.00
11/10/2021	John W. Childs	Director	Buy	5,000	$122.87	$614,350.00
3/17/2021	John W. Childs	Director	Buy	13,157	$76.00	$999,932.00
3/2/2021	John W. Childs	Director	Buy	10,000	$85.14	$851,400.00	2,532,644
11/23/2020	John W. Childs	Director	Buy	5,000	$89.55	$447,750.00	2,516,938
11/2/2020	William A. Jones, Jr.	Insider	Sell	30,000	$76.22	$2,286,600.00	31,755
10/22/2020	Gregory H. Bailey	Director	Sell	24,566	$79.47	$1,952,260.02	2,559,161
10/19/2020	Gregory H. Bailey	Director	Sell	4,554	$78.98	$359,674.92	2,585,181
10/16/2020	Gregory H. Bailey	Director	Sell	3,748	$78.88	$295,642.24	2,585,181
10/12/2020	Gregory H. Bailey	Director	Sell	6,729	$78.87	$530,716.23	2,588,929
10/8/2020	Kimberly Gentile	SVP	Sell	23,500	$76.34	$1,793,990.00	27,139
9/21/2020	John W. Childs	Director	Buy	3,322	$59.25	$196,828.50	2,511,938
9/11/2020	John W. Childs	Director	Buy	6,678	$59.00	$394,002.00	2,508,616
7/8/2020	Gregory H. Bailey	Director	Sell	50,000	$75.22	$3,761,000.00	2,601,649
7/8/2020	Robert Berman	Insider	Sell	58,404	$75.25	$4,394,901.00	58,745
6/24/2020	Gregory H. Bailey	Director	Sell	3,995	$69.86	$279,090.70	2,737,829
6/23/2020	Robert Berman	Insider	Sell	4,296	$75.05	$322,414.80	4,637
6/22/2020	Gregory H. Bailey	Director	Sell	80,331	$73.24	$5,883,442.44	2,973,646
6/19/2020	Gregory H. Bailey	Director	Sell	164,031	$71.22	$11,682,287.82	2,973,646
6/18/2020	Robert Berman	Insider	Sell	61,314	$75.27	$4,615,104.78	36,655
6/17/2020	Kimberly Gentile	SVP	Sell	24,000	$70.20	$1,684,800.00	27,639
6/15/2020	Declan Doogan	Director	Sell	80,000	$66.73	$5,338,400.00	373,913
6/12/2020	Declan Doogan	Director	Sell	160,000	$66.00	$10,560,000.00	373,913
6/12/2020	Elyse Stock	Insider	Sell	36,966	$66.00	$2,439,756.00	22,560
6/11/2020	James Engelhart	CFO	Sell	73,725	$66.00	$4,865,850.00	15,975
6/10/2020	John Tilton	Insider	Sell	52,000	$67.38	$3,503,760.00	52,770
6/8/2020	Kimberly Gentile	SVP	Sell	600	$70.05	$42,030.00	4,239
4/6/2020	John W. Childs	Director	Sell	150,000	$31.25	$4,687,500.00	2,682,279
1/22/2020	Eric Aguiar	Director	Sell	2,021	$56.48	$114,146.08
1/9/2020	Eric Aguiar	Director	Sell	30,000	$56.39	$1,691,700.00	30,000
12/30/2019	Robert Berman	Insider	Sell	125,000	$53.22	$6,652,500.00	125,341
12/16/2019	Eric Aguiar	Director	Sell	3,537	$55.13	$194,994.81
12/9/2019	Eric Aguiar	Director	Sell	4,072	$55.11	$224,407.92
11/22/2019	Eric Aguiar	Director	Sell	1,250	$55.24	$69,050.00	12,000
11/20/2019	Eric Aguiar	Director	Sell	6,729	$52.20	$351,253.80
11/20/2019	Kimberly Gentile	SVP	Sell	3,935	$53.03	$208,673.05	3,935
10/18/2019	Elyse Stock	Insider	Sell	17,700	$45.07	$797,739.00	17,700
10/15/2019	Elyse Stock	Insider	Sell	800	$45.01	$36,008.00	800

Nevada Desert more Valuable than Wall Street or Silicon Valley?

From Investing Trends | Ad

Find Out How to Take Advantage of Nevada's Lithium

SEC Filings (Institutional Ownership Changes) for Biohaven Pharmaceutical (NYSE:BHVN)

78.19% of Biohaven Pharmaceutical stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Biohaven Pharmaceutical Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
9/13/2022	Brown Advisory Inc.	746,074	$108.71M	0.2%	-12.6%	1.043%
8/30/2022	Verition Fund Management LLC	86,490	$12.60M	0.2%	+3,509.8%	0.121%
8/24/2022	Prelude Capital Management LLC	51,361	$7.48M	0.2%	N/A	0.072%
8/22/2022	Legal & General Group Plc	87,333	$12.73M	0.0%	+58.7%	0.122%
8/22/2022	ExodusPoint Capital Management LP	2,466	$0.36M	0.0%	N/A	0.003%
8/19/2022	Walleye Capital LLC	21,354	$3.11M	0.1%	-12.8%	0.030%
8/18/2022	Goldman Sachs Group Inc.	718,679	$104.72M	0.0%	+92.7%	1.005%
8/17/2022	Nomura Holdings Inc.	2,340	$0.33M	0.0%	+134.0%	0.003%
8/17/2022	Parallax Volatility Advisers L.P.	20,004	$2.91M	0.0%	N/A	0.028%
8/16/2022	First Republic Investment Management Inc.	8,116	$1.18M	0.0%	-57.9%	0.011%
8/16/2022	Woodline Partners LP	123,502	$18M	0.3%	N/A	0.173%
8/16/2022	Price T Rowe Associates Inc. MD	521,580	$76M	0.0%	+1.1%	0.729%
8/16/2022	Prudential Financial Inc.	5,406	$0.79M	0.0%	-3.1%	0.008%
8/16/2022	Pentwater Capital Management LP	1,430,000	$208.37M	2.4%	N/A	2.000%
8/16/2022	DAFNA Capital Management LLC	110,100	$16.04M	4.4%	+41.9%	0.154%
8/16/2022	Driehaus Capital Management LLC	50,830	$7.41M	0.1%	N/A	0.071%
8/15/2022	AQR Capital Management LLC	18,737	$2.73M	0.0%	-11.1%	0.026%
8/15/2022	TIG Advisors LLC	1,029,868	$150.06M	6.2%	N/A	1.440%
8/15/2022	State Street Corp	1,745,046	$254.27M	0.0%	+5.4%	2.441%
8/15/2022	Macquarie Group Ltd.	62,875	$9.16M	0.0%	-91.6%	0.088%
8/15/2022	Parallax Volatility Advisers L.P.	20,004	$2.91M	0.0%	N/A	0.028%
8/15/2022	Westchester Capital Management LLC	242,790	$35.38M	1.0%	N/A	0.340%
8/15/2022	Point72 Hong Kong Ltd	1,622	$0.24M	0.0%	-4.0%	0.002%
8/15/2022	Cubist Systematic Strategies LLC	5,154	$0.75M	0.0%	-62.1%	0.007%
8/15/2022	Sio Capital Management LLC	35,000	$5.10M	1.9%	N/A	0.049%
8/15/2022	Voya Investment Management LLC	23,559	$3.43M	0.0%	-66.5%	0.033%
8/15/2022	Sei Investments Co.	54,531	$7.95M	0.0%	+214.7%	0.076%
8/15/2022	Natixis Advisors L.P.	13,251	$1.93M	0.0%	N/A	0.019%
8/15/2022	Soros Fund Management LLC	1,255,001	$182.87M	3.3%	N/A	1.755%
8/15/2022	UBS Asset Management Americas Inc.	338,714	$49.35M	0.0%	+458.8%	0.474%
8/13/2022	Ramius Advisors LLC	20,900	$3.05M	1.5%	N/A	0.029%
8/13/2022	Teacher Retirement System of Texas	9,355	$1.36M	0.0%	-23.3%	0.013%
8/13/2022	Virtu Financial LLC	1,420	$0.21M	0.0%	N/A	0.002%
8/13/2022	Zurcher Kantonalbank Zurich Cantonalbank	7,321	$1.07M	0.0%	-7.4%	0.010%
8/13/2022	Gamco Investors INC. ET AL	20,212	$2.95M	0.0%	N/A	0.028%
8/13/2022	Renaissance Technologies LLC	70,400	$10.26M	0.0%	N/A	0.098%
8/13/2022	Vanguard Personalized Indexing Management LLC	6,327	$0.92M	0.0%	+87.2%	0.009%
8/13/2022	American International Group Inc.	29,157	$4.25M	0.0%	+5.4%	0.041%
8/12/2022	Allianz Asset Management GmbH	235,068	$34.25M	0.0%	+225.4%	0.329%
8/12/2022	Northern Trust Corp	574,770	$83.75M	0.0%	+9.2%	0.804%
8/12/2022	Ensign Peak Advisors Inc	102,726	$14.97M	0.0%	-24.9%	0.144%
8/12/2022	Bardin Hill Management Partners LP	141,207	$20.58M	5.4%	N/A	0.198%
8/12/2022	Hudson Bay Capital Management LP	176,489	$25.72M	0.2%	N/A	0.247%
8/12/2022	Credit Suisse AG	53,423	$7.79M	0.0%	-3.7%	0.075%
8/12/2022	DLD Asset Management LP	25,000	$3.64M	0.3%	N/A	0.035%
8/12/2022	Rafferty Asset Management LLC	26,479	$3.86M	0.0%	-41.2%	0.037%
8/12/2022	Berry Street Capital Management LLP	172,500	$25.14M	3.1%	N/A	0.241%
8/12/2022	FMR LLC	117,508	$17.12M	0.0%	-92.4%	0.164%
8/12/2022	Public Sector Pension Investment Board	180,000	$26.23M	0.2%	N/A	0.252%
8/12/2022	BNP Paribas Arbitrage SA	13,884	$2.02M	0.0%	+146.1%	0.019%
8/12/2022	Rhumbline Advisers	79,483	$11.58M	0.0%	+27.2%	0.111%
8/11/2022	Cetera Advisor Networks LLC	3,030	$0.44M	0.0%	+8.1%	0.004%
8/11/2022	Bridgewater Associates LP	6,308	$0.92M	0.0%	+6.9%	0.009%
8/11/2022	O Shaughnessy Asset Management LLC	2,286	$0.33M	0.0%	+13.3%	0.003%
8/11/2022	Clearbridge Investments LLC	830,776	$121.05M	0.1%	-27.9%	1.162%
8/11/2022	Trexquant Investment LP	3,504	$0.51M	0.0%	N/A	0.005%
8/11/2022	Deutsche Bank AG	98,932	$14.42M	0.0%	-87.2%	0.138%
8/11/2022	Sigma Planning Corp	2,502	$0.37M	0.0%	-61.4%	0.003%
8/11/2022	UBS Group AG	274,026	$39.93M	0.0%	+628.2%	0.383%
8/11/2022	Yakira Capital Management Inc.	55,550	$8.09M	1.3%	N/A	0.078%
8/11/2022	Bank of Montreal Can	44,967	$6.51M	0.0%	N/A	0.063%
8/11/2022	Knott David M Jr	25,051	$3.65M	1.5%	+219.1%	0.035%
8/11/2022	JPMorgan Chase & Co.	876,584	$127.73M	0.0%	-36.0%	1.226%
8/10/2022	Mutual of America Capital Management LLC	34,866	$5.08M	0.1%	-0.7%	0.049%
8/10/2022	Mackenzie Financial Corp	4,253	$0.62M	0.0%	-81.6%	0.006%
8/10/2022	Industrial Alliance Investment Management Inc.	35,770	$5.21M	0.1%	-1.0%	0.051%
8/10/2022	California Public Employees Retirement System	116,708	$17.01M	0.0%	-0.6%	0.165%
8/10/2022	Principal Financial Group Inc.	20,810	$3.03M	0.0%	-18.6%	0.030%
8/10/2022	Inspire Investing LLC	1,453	$0.21M	0.0%	-26.5%	0.002%
8/9/2022	Swiss National Bank	141,300	$20.59M	0.0%	+1.4%	0.200%
8/9/2022	Pictet Asset Management SA	219,848	$32.03M	0.0%	-56.8%	0.312%
8/9/2022	SeaCrest Wealth Management LLC	1,825	$0.27M	0.0%	-34.8%	0.003%
8/9/2022	Lazard Asset Management LLC	1,243	$0.18M	0.0%	+42.1%	0.002%
8/9/2022	Alpine Associates Management Inc.	533,800	$77.78M	2.9%	N/A	0.757%
8/8/2022	Keebeck Alpha LP	20,562	$3M	1.3%	N/A	0.029%
8/8/2022	AdvisorShares Investments LLC	2,288	$0.33M	0.1%	N/A	0.003%
8/8/2022	Advisors Asset Management Inc.	8,672	$1.26M	0.0%	-63.3%	0.012%
8/8/2022	Walleye Capital LLC	21,354	$3.11M	0.1%	-12.8%	0.030%
8/8/2022	BCK Capital Management LP	9,231	$1.35M	1.0%	N/A	0.013%
8/8/2022	Oppenheimer Asset Management Inc.	7,644	$1.11M	0.0%	-3.9%	0.011%
8/8/2022	Rice Hall James & Associates LLC	263,030	$38.33M	1.9%	-5.0%	0.373%
8/8/2022	Bank of Nova Scotia	4,877	$0.71M	0.0%	-8.0%	0.007%
8/8/2022	OneAscent Wealth Management LLC	1,524	$0.22M	0.1%	N/A	0.002%
8/8/2022	Curi Wealth Management LLC	1,725	$0.25M	0.0%	N/A	0.002%
8/8/2022	Compass Financial Advisors LLC	2,653	$0.39M	0.5%	-18.4%	0.004%
8/8/2022	Meeder Asset Management Inc.	408	$59K	0.0%	N/A	0.001%
8/5/2022	State Board of Administration of Florida Retirement System	19,293	$2.81M	0.0%	+7.8%	0.027%
8/5/2022	Mint Tower Capital Management B.V.	9,218	$1.34M	0.1%	N/A	0.013%
8/5/2022	Illinois Municipal Retirement Fund	4,887	$0.71M	0.0%	N/A	0.007%
8/5/2022	Los Angeles Capital Management LLC	4,911	$0.72M	0.0%	-25.7%	0.007%
8/4/2022	Carret Asset Management LLC	1,683	$0.25M	0.0%	N/A	0.002%
8/3/2022	Envestnet Asset Management Inc.	33,204	$4.84M	0.0%	+11.2%	0.047%
8/3/2022	Nisa Investment Advisors LLC	4,392	$0.64M	0.0%	+18.6%	0.006%
8/3/2022	Janney Montgomery Scott LLC	3,421	$0.50M	0.0%	+76.6%	0.005%
8/3/2022	Wolverine Asset Management LLC	10,465	$1.52M	0.0%	N/A	0.015%
8/3/2022	Candriam S.C.A.	144,428	$21.04M	0.2%	N/A	0.205%
8/3/2022	Handelsbanken Fonder AB	64,600	$9.41M	0.1%	-76.8%	0.092%
8/2/2022	Pinnacle Wealth Management Group Inc.	1,600	$0.23M	0.2%	N/A	0.002%
8/2/2022	KRS Capital Management LLC	3,815	$0.56M	0.8%	-34.4%	0.005%
8/2/2022	Banque Cantonale Vaudoise	294	$43K	0.0%	-32.7%	0.000%

Data available starting January 2016

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as respiratory complications and non-migraine studies; and BHV-3100 for non-migraine indications. The company also offers Troriluzole for spinocerebellar ataxia and obsessive compulsive disorders, as well as Alzheimer diseases; BHV-0223, a product for amyotrophic lateral sclerosis; BHV-5000/5500 for neuropsychiatric indications; and Verdiperstat, a product for multiple system atrophy and amyotrophic lateral sclerosis. Biohaven Pharmaceutical Holding Company Ltd. has a collaboration agreement with Cove to facilitate telemedicine evaluation for migraine sufferers. The company was incorporated in 2013 and is headquartered in New Haven, Connecticut.

Today's Range

Now: $152.40

$152.15

$152.43

50 Day Range

MA: $148.70

$145.95

$152.20

52 Week Range

Now: $152.40

$79.01

$152.56

Volume

16,458 shs

Average Volume

920,215 shs

Market Capitalization

$10.92 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Who are the company insiders with the largest holdings of Biohaven Pharmaceutical?: Biohaven Pharmaceutical's top insider shareholders include:
Gregory Bailey (Director)
John W Childs (Director)
William A Jones Jr (Insider)
Kimberly Gentile (SVP)
George C Clark (CAO)
Declan Doogan (Director)
Elyse Stock (Insider)
James Engelhart (CFO)
Julia P Gregory (Director)
Learn More about top insider investors at Biohaven Pharmaceutical.
Who are the major institutional investors of Biohaven Pharmaceutical?: Biohaven Pharmaceutical's top institutional shareholders include:
State Street Corp — 2.44%
Pentwater Capital Management LP — 2.00%
Soros Fund Management LLC — 1.76%
TIG Advisors LLC — 1.44%
Allspring Global Investments Holdings LLC — 1.29%
JPMorgan Chase & Co. — 1.23%
Learn More about top institutional investors of Biohaven Pharmaceutical stock.
Which major investors are selling Biohaven Pharmaceutical stock?: During the last quarter, BHVN stock was sold by these institutional investors:
FMR LLC
Allspring Global Investments Holdings LLC
Macquarie Group Ltd.
Deutsche Bank AG
JPMorgan Chase & Co.
ARS Investment Partners LLC
Clearbridge Investments LLC
Pictet Asset Management SA
In the last year, company insiders that have sold Biohaven Pharmaceutical company stock include:
Gregory Bailey (Director)
John W Childs (Director)
William A Jones Jr (Insider)
Kimberly Gentile (SVP)
George C Clark (CAO)
Learn More investors selling Biohaven Pharmaceutical stock.
Which major investors are buying Biohaven Pharmaceutical stock?: Within the previous quarter, BHVN stock was acquired by institutional investors including:
Pentwater Capital Management LP
Soros Fund Management LLC
TIG Advisors LLC
Versor Investments LP
Alpine Associates Management Inc.
Goldman Sachs Group Inc.
UBS Asset Management Americas Inc.
Westchester Capital Management LLC
During the last year, these company insiders have bought Biohaven Pharmaceutical stock:
Gregory Bailey (Director)
John W Childs (Director)
Learn More investors buying Biohaven Pharmaceutical stock.

Nevada Desert more Valuable than Wall Street or Silicon Valley?

From Investing Trends | Ad

Find Out How to Take Advantage of Nevada's Lithium

BHVN Insider Trading

Biohaven Pharmaceutical Insider Trading History Chart

Biohaven Pharmaceutical Share Price & Price History

Biohaven Pharmaceutical Insider Trading History

SEC Filings (Institutional Ownership Changes) for Biohaven Pharmaceutical (NYSE:BHVN)

Institutional Buying and Selling by Quarter

Biohaven Pharmaceutical Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Biohaven Pharmaceutical?

Who are the major institutional investors of Biohaven Pharmaceutical?

Which major investors are selling Biohaven Pharmaceutical stock?

Which major investors are buying Biohaven Pharmaceutical stock?